Michael Shorb, dearly beloved husband of Judith Grogan-Shorb, passed away on August 8, 2012, from a very rare cancer. Born October 29, 1943, he was the son of the late Robert Shorb and Helen Thisted Shorb; brother to the late Beverly Gonzales and Paul Shorb. His other brothers and sisters: Jan Jupp, Myrna Todd, Keith Shorb, Nadine Morris, Bill Shorb and Glen Shorb. Michael was a poet and was published in over 100 poetry magazines and poetry anthologies.
Life Raft Group member Jason DeLorenzo held his annual “DeLoBQ” fundraiser last month in Alexandria, Virginia. The BBQ has raised almost $2,000 thus far, and donations are still coming! Jason explains the growing success of [...]
A new study published by Clinical Cancer Research found that crenolanib is a potent inhibitor of imatinib resistant PDGFRA kinases associated with Gastrointestinal Stromal Tumor, including the PDGFRA D842V mutation found in about 5 percent [...]
Pfizer Pharmaceuticals is offering Sutent in Touch, a program to support GIST patients on its drug Sutent. The program is free and patients can sign up by calling (1-877-578-8368). Sutent in Touch links patients to Oncology [...]
The first in a series of New York Times articles by science writer Gina Kolata on new approaches to cancer treatment underscored the type of cutting-edge approaches taken by the Life Raft Group’s own team of researchers. [...]
Social Media, such as Twitter, Facebook and LinkedIn, are an integral part of the daily lives of millions of people all over the world. People of all ages and backgrounds use social media, and now [...]
An agreement to secure the entry of Gleevec for Guatemalan GIST and chronic myeloid leukemia patients was reached with the Central American country’s government July 10, following advocacy efforts by Novartis Pharmaceuticals, Alianza GIST and [...]
Alianza GIST and Oncoguia have formalized a new partnership to work together to benefit GIST patients in Brazil. The first goal of this partnership is to identify GIST patients in the different regions of [...]
A new clinical trial combining targeted therapy with immunotherapy has just opened at Memorial Sloan-Kettering Cancer Center (MSKCC). This trial is the culmination of extensive pre-clinical investigations by MSKCC researchers. Although treatment with Gleevec [...]
The Clinic is a collaboration between clinicians and researchers to collect data, investigate and develop treatment for Gastrointestinal Stromal Tumor patients who do not have either c-KIT or Platelet -Derived Growth Factor Receptor alpha (PDGFRA) mutations. This includes patients with Carney’s Triad, Carney- Stratakis Dyad, and Wildtype GIST. These tumors frequently stain negatively for a protein called Succinate Dehydrogenase, a condition referred to as being Succinate Dehydrogenasedeficient (SDH-deficient). There are currently three clinical trials in development for this population.